Joel Isaacson & Co’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$802K Hold
10,247
0.02% 238
2026
Q1
$662K Hold
10,247
0.02% 240
2025
Q4
$690K Hold
10,247
0.02% 237
2025
Q3
$752K Hold
10,247
0.03% 212
2025
Q2
$533K Hold
10,247
0.02% 245
2025
Q1
$654K Hold
10,247
0.03% 209
2024
Q4
$490K Sell
10,247
-215
-2% -$11K 0.02% 232
2024
Q3
$599K Hold
10,462
0.03% 192
2024
Q2
$548K Hold
10,462
0.03% 199
2024
Q1
$426K Hold
10,462
0.02% 233
2023
Q4
$387K Hold
10,462
0.02% 224
2023
Q3
$400K Hold
10,462
0.03% 213
2023
Q2
$377K Hold
10,462
0.03% 223
2023
Q1
$400K Hold
10,462
0.03% 209
2022
Q4
$595K Hold
10,462
0.05% 157
2022
Q3
$414K Hold
10,462
0.04% 184
2022
Q2
$460K Sell
10,462
-288
-3% -$12.5K 0.04% 173
2022
Q1
$449K Hold
10,750
0.03% 188
2021
Q4
$432K Hold
10,750
0.03% 208
2021
Q3
$437K Hold
10,750
0.03% 199
2021
Q2
$488K Hold
10,750
0.04% 181
2021
Q1
$448K Buy
10,750
+1,750
+19% +$79.9K 0.04% 165
2020
Q4
$384K Buy
+9,000
New +$324K 0.04% 175
2017
Q1
Sell
-2,538
Closed -$25K 321
2016
Q4
$25K Hold
2,538
0.01% 406
2016
Q3
$31K Hold
2,538
0.01% 403
2016
Q2
$22K Hold
2,538
﹤0.01% 451
2016
Q1
$24K Buy
2,538
+1,000
+65% +$9.41K 0.01% 461
2015
Q4
$27K Hold
1,538
0.01% 424
2015
Q3
$21K Hold
1,538
0.01% 470
2015
Q2
$35K Hold
1,538
0.01% 410
2015
Q1
$22K Buy
+1,538
New +$22.2K 0.01% 475

Other funds holding HALO

Joel Isaacson & Co's HALO Position: Q2 2026 in Review

Joel Isaacson & Co held its Halozyme (HALO) position steady in Q2 2026 at 10,247 shares worth $802K. The position accounts for 0.02% of the portfolio, ranked #238.

Joel Isaacson & Co first reported a position in HALO in Q1 2015 and has held it in 31 quarters since. 344 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Joel Isaacson & Co held 10,247 shares of Halozyme worth $802K as of Q2 2026.
  • Joel Isaacson & Co left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up 0.02% of Joel Isaacson & Co's portfolio in Q2 2026, its #238 holding.
  • Joel Isaacson & Co first reported a position in Halozyme in Q1 2015 and has held it in 31 quarters since.
  • 344 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Joel Isaacson & Co's 13F filing for Q2 2026, filed 4 Aug 2026.